Navigation Links
Medarex Hosts June 2nd Webcast of Ipilimumab Data Presented at ASCO

PRINCETON, N.J., May 30 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) is scheduled to host a webcast review of the ipilimumab data presented during the Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. As previously announced, the live webcast will begin at 8:00 a.m. Eastern Time / 7:00 a.m. Central Time on Monday, June 2, 2008. Medarex senior management will be joined by Jedd D. Wolchok, M.D., Ph.D., Director of Immunotherapy Clinical Trials at Memorial Sloan-Kettering Cancer Center in New York.

The webcast can be accessed on Medarex's website at and will be archived and available for at least 14 days.

About Medarex

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb(R) technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. More than 40 of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with seven of the most advanced product candidates currently in Phase 3 clinical trials or the subject of regulatory applications for marketing authorization. Medarex is committed to building value by developing a diverse pipeline of antibody products to address the world's unmet healthcare needs. For more information about Medarex, visit its website at

Medarex(R), the Medarex logo and UltiMAb(R) are registered trademarks of Medarex, Inc. All rights are reserved.

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Medarex Announces 2008 First Quarter Financial Results
2. Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
3. Medarex Announces 2007 Fourth Quarter and Year End Financial Results
4. Medarex to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
5. Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
6. PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)
7. Medarex to Present at the JPMorgan Small/Mid Cap Conference
8. Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody
9. SNM hosts 55th Annual Meeting of Nuclear Medicine and Molecular Imaging Research
10. TriWest Hosts Military Heroes at National Memorial Day Parade
11. American Red Cross Hosts Heritage of Service Dinner
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... Sir Grout of Greater Boston donated an expansive, ... of Ronald McDonald House Charities® (RMHC®). This donation was made in an effort to ... Boston since its inception. , “We believe strongly in the Ronald McDonald House Charities, ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... platform, ENGAGE, at HIMSS’s Patient Engagement Summit . HealthAware is a technology ... innovative health programs and interventions via mobile devices that provide a framework for ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... of IBM software products, introduced a new company, RightSensor™ LLC, an Internet of ... communications capability. RightSensor™ provides a fully-managed approach for customers requiring sensor hardware ...
(Date:10/13/2015)... NY (PRWEB) , ... October 13, 2015 , ... NavaFit ... app helps individuals find others to train with, participate in local fitness & ... Store and Google Play. , “As high medical costs drive us to get more ...
(Date:10/13/2015)... ... October 13, 2015 , ... Nordic ... unique health needs of new moms. Postnatal Omega-3, which has been named ... utilizes Nordic Naturals’ exclusive, new, ultra-concentrated omega-3 oil. This breakthrough oil combines ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... , Oct. 13, 2015 According ... (NCPA) Digest , sponsored by Cardinal Health ... medication and more diversified pharmacy revenue streams are ... pharmacies. NCPA Digest affirms ... and particularly those in underserved inner city and ...
(Date:10/13/2015)... PITTSBURGH , Oct. 13, 2015  Data Science Automation ... the opening of a new branch office in the ... of DSA,s presence in Europe . The ... the increasing demand for local support of customers in the ... , Ph.D., DSA,s UK Branch Manager. "We have had tremendous ...
(Date:10/13/2015)... , Oct. 13, 2015  Nanomedical Diagnostics, ... use in research and diagnostics, announces the completion ... million led by Serra Ventures. ... is providing low-cost, easy-to-use monitoring and diagnostic platforms ... decisions. The funding round will enable the company ...
Breaking Medicine Technology: